Role of central obesity in risk stratification after an acute coronary event: D...

• Autor(es): Martins, A ; Ribeiro, S ; Gonçalves, P ; Correia, A
• Data: 2013
• Identificador Persistente: http://hdl.handle.net/10400.23/579
• Origem: Repositório Científico do Hospital de Braga
• Assunto(s): Doença Coronária; Enfarte do Miocárdio; Obesidade; Síndrome Coronária Aguda; Avaliação do Risco
• Tipo de Documento: Artigo
• Idioma: Inglês

Descrição

BACKGROUND: Accurate risk stratification is an important step in the initial management of acute coronary syndrome (ACS), and current guidelines recommend the use of risk scores, such as the Global Registry of Acute Coronary Events risk score (GRACE RS). Recent studies have suggested that abdominal obesity is associated with cardiovascular events in patients with ACS. However, little is known about the additional value of abdominal obesity beyond risk scores. The aim of our study was thus to assess whether waist circumference, a surrogate of abdominal adiposity, adds prognostic information to the GRACE RS. METHODS: This was a retrospective cohort study of ACS patients admitted consecutively to a cardiac care unit between June 2009 and July 2010. The composite of all-cause mortality or myocardial reinfarction within six months of index hospitalization was used as the endpoint for the analysis. RESULTS: A total of 285 patients were studied, 96.1% admitted for myocardial infarction (with or without ST elevation) and 3.9% for unstable angina. At the end of the follow-up period, 10 patients had died and the composite endpoint had been reached in 27 patients (9.5%). More than 70% of the study population were obese or overweight, and abdominal obesity was present in 44.6%. The GRACE RS showed poor predictive accuracy (area under the curve 0.60), and most of the GRACE variables did not reach statistical significance in multivariate analysis. The addition of waist circumference to the GRACE RS did not improve its discriminatory performance. CONCLUSION: Abdominal obesity does not add prognostic information to the GRACE RS to predict six-month mortality or myocardial reinfarction